Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC — Form D
Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC of Salt Lake City, UT, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-11-13. The offering totals $154K, of which $154K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-11-13
- Form: D
- Accession: 0001786499-19-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Total offering: $154K
- Amount sold: $154K
- Minimum investment: $5K
- Investors: 24
- Date of first sale: 2019-11-12
- Security types: fund interests
- SEC file number: 021-353256
Issuer
- Name: Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC
- CIK: 0001786499
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6510 South Millrock Drive, Salt Lake City, UT, 84121
- Phone: (801) 419-0677
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
| Richard Thoms | Executive Officer | Salt Lake City, UT |
| Jeremy llc Neilson | Executive Officer | Salt Lake City, UT |
| Richard llc Thoms | Executive Officer | Salt Lake City, UT |
| LLC LP Assure Fund Management II | Director | Salt Lake City, UT |
Other filings by this issuer (1)
More